Susquehanna International Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.5M | Sell |
|
|||||
|
2025
Q2 | $2.16M | Sell |
|
|||||
|
2025
Q1 | $2.63M | Buy |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | $626K | Buy |
|
|||||
|
2024
Q2 | $332K | Buy |
|
|||||
|
2024
Q1 | $217K | Sell |
|
|||||
|
2023
Q4 | $470K | Sell |
|
|||||
|
2023
Q3 | $1.01M | Sell |
|
|||||
|
2023
Q2 | $1.4M | Buy |
|
|||||
|
2023
Q1 | $1.65M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $567K | Buy |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $823K | Buy |
|
|||||
|
2021
Q3 | $501K | Buy |
|
|||||
|
2021
Q2 | $333K | Sell |
|
|||||
|
2021
Q1 | $1.25M | Buy |
|
|||||
|
2020
Q4 | $998K | Buy |
|
|||||
|
2020
Q3 | $274K | Sell |
|
|||||
|
2020
Q2 | $685K | Buy |
|
|||||
|
2020
Q1 | $304K | Sell |
|
|||||
|
2019
Q4 | $1.19M | Sell |
|
|||||
|
2019
Q3 | $3.56M | Buy |
|
|||||
|
2019
Q2 | $2.92M | Buy |
|
|||||
|
2019
Q1 | $632K | Sell |
|
|||||
|
2018
Q4 | $3.93M | Buy |
|
|||||
|
2018
Q3 | $674K | Sell |
|
|||||
|
2018
Q2 | $830K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.92M | Sell |
|
|||||
|
2017
Q3 | $4.04M | Buy |
|
|||||
|
2017
Q2 | $2.28M | Buy |
|
|||||
|
2017
Q1 | $1.33M | Sell |
|
|||||
|
2016
Q4 | $4.5M | Buy |
|
|||||
|
2016
Q3 | $1.05M | Hold |
|
|||||
|
2016
Q2 | $865K | Buy |
|
|||||
|
2016
Q1 | $390K | Buy |
|
|||||
|
2015
Q4 | $207K | Sell |
|
|||||
|
2015
Q3 | $462K | Buy |
|
|||||
|
2015
Q2 | $417K | Sell |
|
|||||
|
2015
Q1 | $349K | Sell |
|
|||||
|
2014
Q4 | $426K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $133K | Sell |
|
|||||
|
2014
Q1 | $476K | Sell |
|
|||||
|
2013
Q4 | $3.14M | Buy |
|
|||||
|
2013
Q3 | $162K | Buy |
|
|||||
|
2013
Q2 | $64K | Buy |
|